Scientific Literature Search

Source record

Parkinson's disease: from genetics to treatments.

Fan HC, Chen SJ, Harn HJ, Lin SZ.

Cell Transplant · 2012-10-31

DOI: 10.3727/096368912x655082PMID: 23127617

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Oxidative stress and tardive dyskinesia: pharmacogenetic evidence.

Cho CH, Lee HJ.

Prog Neuropsychopharmacol Biol Psychiatry · 2012-10-31

DOI: 10.1016/j.pnpbp.2012.10.018PMID: 23123399

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Genetics of Parkinson's disease - a clinical perspective.

Cheon SM, Chan L, Chan DK, Kim JW.

J Mov Disord · 2012-10-30

DOI: 10.14802/jmd.12009PMID: 24868412

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

A rationally designed six-residue swap generates comparability in the aggregation behavior of α-synuclein and β-synuclein.

Roodveldt C, Andersson A, De Genst EJ, Labrador-Garrido A, Buell AK, Dobson CM, Tartaglia GG, Vendruscolo M.

Biochemistry · 2012-10-22

DOI: 10.1021/bi300558qPMID: 23003198

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects.

Aboud AA, Tidball AM, Kumar KK, Neely MD, Ess KC, Erikson KM, Bowman AB.

Neurotoxicology · 2012-10-22

DOI: 10.1016/j.neuro.2012.10.009PMID: 23099318

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Inhibitors of LRRK2 kinase activity to probe the treatment option in Parkinson's disease.

Rautio J.

J Med Chem · 2012-10-18

DOI: 10.1021/jm301460xPMID: 23078245

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations.

Trancikova A, Mamais A, Webber PJ, Stafa K, Tsika E, Glauser L, West AB, Bandopadhyay R, Moore DJ.

PLoS One · 2012-10-17

DOI: 10.1371/journal.pone.0047784PMID: 23082216

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Progressive degeneration of human neural stem cells caused by pathogenic LRRK2.

Liu GH, Qu J, Suzuki K, Nivet E, Li M, Montserrat N, Yi F, Xu X, Ruiz S, Zhang W, Wagner U, Kim A, Ren B, Li Y, Goebl A, Kim J, Soligalla RD, Dubova I, Thompson J, Yates J, Esteban CR, Sancho-Martinez I, Izpisua Belmonte JC.

Nature · 2012-10-17

DOI: 10.1038/nature11557PMID: 23075850

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Optogenetic investigation of neuropsychiatric diseases.

Huang F, Tang B, Jiang H.

Int J Neurosci · 2012-10-16

DOI: 10.3109/00207454.2012.728651PMID: 23002710

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Radiating amyloid fibril formation on the surface of lipid membranes through unit-assembly of oligomeric species of α-synuclein.

Lee JH, Hong CS, Lee S, Yang JE, Park YI, Lee D, Hyeon T, Jung S, Paik SR.

PLoS One · 2012-10-15

DOI: 10.1371/journal.pone.0047580PMID: 23077644

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors.

Estrada AA, Liu X, Baker-Glenn C, Beresford A, Burdick DJ, Chambers M, Chan BK, Chen H, Ding X, DiPasquale AG, Dominguez SL, Dotson J, Drummond J, Flagella M, Flynn S, Fuji R, Gill A, Gunzner-Toste J, Harris SF, Heffron TP, Kleinheinz T, Lee DW, Le Pichon CE, Lyssikatos JP, Medhurst AD, Moffat JG, Mukund S, Nash K, Scearce-Levie K, Sheng Z, Shore DG, Tran T, Trivedi N, Wang S, Zhang S, Zhang X, Zhao G, Zhu H, Sweeney ZK.

J Med Chem · 2012-10-15

DOI: 10.1021/jm301020qPMID: 22985112

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Vitamins K interact with N-terminus α-synuclein and modulate the protein fibrillization in vitro. Exploring the interaction between quinones and α-synuclein.

da Silva FL, Coelho Cerqueira E, de Freitas MS, Gonçalves DL, Costa LT, Follmer C.

Neurochem Int · 2012-10-12

DOI: 10.1016/j.neuint.2012.10.001PMID: 23064431

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

15.286 articles found

Parkinson's disease: from genetics to treatments.

Oxidative stress and tardive dyskinesia: pharmacogenetic evidence.

Genetics of Parkinson's disease - a clinical perspective.

A rationally designed six-residue swap generates comparability in the aggregation behavior of α-synuclein and β-synuclein.

Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects.

Inhibitors of LRRK2 kinase activity to probe the treatment option in Parkinson's disease.

Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations.

Progressive degeneration of human neural stem cells caused by pathogenic LRRK2.

Optogenetic investigation of neuropsychiatric diseases.

Radiating amyloid fibril formation on the surface of lipid membranes through unit-assembly of oligomeric species of α-synuclein.

Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors.

Vitamins K interact with N-terminus α-synuclein and modulate the protein fibrillization in vitro. Exploring the interaction between quinones and α-synuclein.

Filters